CINECA IRIS Institutional Research Information System

PIGNOCHINO, Ymera
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.625
EU - Europa 1.616
AS - Asia 983
SA - Sud America 49
OC - Oceania 11
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.294
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.523
CN - Cina 573
IT - Italia 555
DE - Germania 224
IE - Irlanda 142
GB - Regno Unito 140
SE - Svezia 98
FR - Francia 97
JP - Giappone 89
CA - Canada 87
SG - Singapore 85
ES - Italia 53
FI - Finlandia 52
KR - Corea 50
UA - Ucraina 49
VN - Vietnam 48
PL - Polonia 38
BR - Brasile 29
TR - Turchia 27
IN - India 26
TW - Taiwan 26
NL - Olanda 24
AT - Austria 23
HK - Hong Kong 20
BE - Belgio 19
NO - Norvegia 17
RU - Federazione Russa 16
CH - Svizzera 15
TH - Thailandia 12
AU - Australia 11
MX - Messico 11
PT - Portogallo 9
HR - Croazia 8
AR - Argentina 7
CO - Colombia 6
SA - Arabia Saudita 6
GR - Grecia 5
IL - Israele 5
RO - Romania 5
HU - Ungheria 4
LT - Lituania 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
IR - Iran 3
MK - Macedonia 3
PA - Panama 3
ZA - Sudafrica 3
AM - Armenia 2
EU - Europa 2
JO - Giordania 2
MA - Marocco 2
RS - Serbia 2
SN - Senegal 2
BT - Bhutan 1
CL - Cile 1
EE - Estonia 1
EG - Egitto 1
ID - Indonesia 1
LU - Lussemburgo 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 5.294
Salva come PNG Salva come JPEG
Città #
Chandler 316
Beijing 194
Fairfield 194
Dublin 141
Woodbridge 128
Ann Arbor 125
Houston 116
Torino 115
Ashburn 111
Seattle 94
Wilmington 79
Mcallen 75
Cambridge 71
Shanghai 67
Munich 66
Nyköping 59
Montréal 58
Turin 57
Jacksonville 56
Redwood City 52
Milan 51
Singapore 51
Medford 50
Dearborn 49
Pisa 42
Villeurbanne 42
Princeton 41
Guangzhou 36
Warsaw 32
Hangzhou 29
Dong Ket 28
Nanjing 24
Fremont 20
Cuneo 19
New York 18
Tokyo 17
Boston 16
Madrid 15
San Diego 15
Taipei 15
Vienna 14
Wuhan 13
Dresden 12
Hebei 12
Xian 12
Brussels 11
Changsha 11
Rome 11
Stavanger 11
Zhengzhou 11
Hong Kong 10
Los Angeles 10
Seoul 10
Bari 9
Chengdu 9
Kunming 9
Berlin 8
Carrara 8
Hefei 8
Heidelberg 8
Ottawa 8
Tianjin 8
Upper Marlboro 8
Buenos Aires 7
Istanbul 7
Paris 7
Washington 7
Amsterdam 6
Brescia 6
Falls Church 6
Helsinki 6
Mountain View 6
New Haven 6
Norwalk 6
Padova 6
Phoenix 6
Silver Spring 6
St Petersburg 6
Toronto 6
Tübingen 6
A Coruña 5
Birmingham 5
Cagliari 5
Chicago 5
Columbus 5
Esslingen 5
Fuzhou 5
Genoa 5
Graz 5
Jinan 5
Mumbai 5
Paredes 5
Rochester 5
Settimo Torinese 5
Seville 5
Stuttgart 5
Verona 5
Boardman 4
Bologna 4
Brookline 4
Totale 3.218
Salva come PNG Salva come JPEG
Nome #
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial 1.042
Prolonged disease stability with trabectedin in a heavily pretreated elderly patient with metastatic leiomyosarcoma of the thigh and renal failure: a case report and review of the literature. 323
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells 309
Phage Display-Based Nanotechnology Applications in Cancer Immunotherapy 298
Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group 295
PARP1 expression drives the synergistic antitumor activity of trabectedin and PARP1 inhibitors in sarcoma preclinical models 195
Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas. 177
The combination of sorafenib and everolimus shows antitumor activity in preclinical models of malignant pleural mesothelioma 149
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells 143
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 135
Pazopanib and trametinib as a synergistic strategy against osteosarcoma: Preclinical activity and molecular insights 132
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways 119
Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma 115
Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas 102
ZnO nanocrystals shuttled by extracellular vesicles as effective Trojan nano-horses against cancer cells 102
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 98
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. 96
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab 93
Multilineage engraftment of refrozen cord blood hematopoietic progenitors in NOD/SCID mice 91
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination 83
Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions 82
Adoptive immunotherapy against sarcomas. 78
Feasibility of cord blood stem cell manipulation with high-energy shock waves: an in vitro and in vivo study 77
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. 76
Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer. 69
Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group 66
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features. 63
Sustained Long Term Engraftment and Transgene Expression of Peripheral Blood CD34+ Cells Transduced with Third-Generation Lentiviral Vectors 63
Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation 62
Tumor cell purging by ex vivo expansion of hemopoietic stem cells from breast cancer patients combined with targeting ErbB receptors 61
Impact of a risk-based follow-up in patients affected by gastrointestinal stromal tumour 61
Pemetrexed-loaded nanoparticles targeted to malignant pleural mesothelioma cells: An in vitro study 61
Crosstalk between macrophages and myxoid liposarcoma cells increases spreading and invasiveness of tumor cells 59
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma 56
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective Series 53
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 50
Sorafenib blocks tumour growth, angiogenesis and metastatic potential in preclinical models of osteosarcoma through a mechanism potentially involving the inhibition of ERK1/2, MCL-1 and ezrin pathways 49
The Combination of Sorafenib and Everolimus abrogates mTORC-1 and mTORC2 up-regulation in preclinical models of Osteosarcoma. 47
Delving into PARP inhibition from bench to bedside and back 43
Enhancing proteotoxic stress in leiomyosarcoma cells triggers mitochondrial dysfunctions, cell death, and antitumor activity in vivo 43
Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma 34
Targeting of epidermal growth factor receptor in patients affected by biliary tract carcinoma 33
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST 30
Generation and characterization of two primary cultures of osteosarcoma and Ewing’s sarcoma 11
Preclinical models of tumour-specific cytotoxic T lymphocytes in sarcoma patients 9
CD99 Modulates the Proteomic Landscape of Ewing Sarcoma Cells and Related Extracellular Vesicles 6
Exosome-Based Liquid Biopsy Approaches in Bone and Soft Tissue Sarcomas: Review of the Literature, Prospectives, and Hopes for Clinical Application 4
AI Based Discovery of a New AKR1C3 Inhibitor for Anticancer Applications 4
Comprehensive Molecular Profiling of NPM1-Mutated Acute Myeloid Leukemia Using RNAseq Approach 3
Targeted lipid-coated ZnO nanoparticles coupled with ultrasound: A sonodynamic approach for the treatment of osteosarcoma as 3D spheroid models 1
Totale 5.451
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.058
article - articoli 0
book - libri 0
conference - conferenze 525
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.583
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020874 55 57 38 78 46 103 83 71 95 94 84 70
2020/2021805 76 102 82 70 59 72 38 54 55 80 31 86
2021/2022826 119 48 38 53 34 40 44 46 29 72 173 130
2022/2023962 79 89 31 105 65 205 76 56 108 34 74 40
2023/2024591 62 95 31 50 47 67 23 40 12 36 68 60
2024/202526 26 0 0 0 0 0 0 0 0 0 0 0
Totale 5.451